Osheru secures $4.7 million in seed funding led by individuals and family offices, including investment from Nike Co-Founder Phil Knight, to advance revolutionary Ziplyft device for blepharoplasty surgery.

Osheru, a medical device company specializing in innovative solutions for skin surgery, has successfully completed a $4.7 million seed funding round to accelerate the development and commercialization of its groundbreaking Ziplyft device for blepharoplasty surgery. The funding round, led by individuals and family offices, including investment from Nike Co-Founder Phil Knight, reflects robust investor confidence in Osheru’s transformative approach to eyelid surgery.